MITOMYCIN - 10 YEARS AFTER APPROVAL FOR MARKETING

被引：107

作者：

DOLL, DC

WEISS, RB

ISSELL, BF

机构：

[1] WALTER REED ARMY MED CTR,MED ONCOL SECT,WASHINGTON,DC 20012

[2] UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814

[3] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201

[4] SUNY UPSTATE MED CTR,SYRACUSE,NY 13210

来源：

关键词：

D O I：

10.1200/JCO.1985.3.2.276

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：276 / 286

页数：11

共 147 条

[21] MITOMYCIN-C - REVIEW
CROOKE, ST
BRADNER, WT
[J]. CANCER TREATMENT REVIEWS, 1976, 3 (03) : 121 - 139
[22] CROOKE ST, 1976, CANCER TREAT REP, V60, P1633
[23] DABROWIAK JC, 1982, ADV INORG BIOCH, V4, P66
[24] DENHARTIGH J, 1983, CANCER RES, V43, P5017
[25] CHEMOTHERAPEUTIC-AGENTS AND THE ERYTHRON
DOLL, DC
WEISS, RB
[J]. CANCER TREATMENT REVIEWS, 1983, 10 (03) : 185 - 200
[26] DOROSHOW JH, 1981, J PHARMACOL EXP THER, V218, P206
[27] AN INTERIM-REPORT OF A PROSPECTIVE, RANDOMIZED, CONTROLLED-STUDY OF ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC-CANCER - BRITISH STOMACH-CANCER GROUP
FIELDING, JWL
FAGG, SL
JONES, BG
ELLIS, D
HOCKEY, MS
MINAWA, A
BROOKES, VS
CRAVEN, JL
MASON, MC
TIMOTHY, A
WATERHOUSE, JAH
WRIGLEY, PFM
[J]. WORLD JOURNAL OF SURGERY, 1983, 7 (03) : 390 - 399
[28] FLAM MS, 1983, CANCER, V51, P1378, DOI 10.1002/1097-0142(19830415)51:8<1378::AID-CNCR2820510810>3.0.CO
[29] 2-F
[30] FRANK W, 1960, CANCER CHEMOTH REP, V9, P114